DISRUPTING DISEASE
LIVE

Serial Number

98609018

Owner

Alnylam Pharmaceuticals, Inc.

Attorney

Jennifer Kwon

Filing Date

Jun 19, 2024

Add to watchlist:

No watchlists yet
View on USPTO

DISRUPTING DISEASE Trademark

Serial Number: 98609018 • Registration: 7869579

DISRUPTING DISEASE is a trademark filed by Alnylam Pharmaceuticals, Inc. on June 19, 2024. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Alnylam Pharmaceuticals, Inc. (91 trademarks)

300 Third Street, 3rd Floor
Cambridge, MA 02142

Entity Type: 03

Trademark Details

Filing Date

June 19, 2024

Registration Date

July 15, 2025

Goods & Services

Scientific research; scientific research in the fields of pharmaceuticals and medicine; chemical laboratories; medical research laboratories; providing scientific information in the field of biopharmaceuticals

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 15, 2025 NRCS
REGISTERED-SUPPLEMENTAL REGISTER
Jul 15, 2025 R.SR
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Jun 13, 2025 CNTA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 14, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 14, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 14, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 21, 2025 GNRN
NON-FINAL ACTION E-MAILED
Feb 21, 2025 GNRT
NON-FINAL ACTION WRITTEN
Feb 21, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 25, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 25, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 25, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 29, 2024 GNRN
NON-FINAL ACTION E-MAILED
Oct 29, 2024 GNRT
NON-FINAL ACTION WRITTEN
Oct 29, 2024 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 29, 2024 GNRN
NON-FINAL ACTION E-MAILED
Oct 29, 2024 GNRT
NON-FINAL ACTION WRITTEN
Oct 29, 2024 CNRT
ASSIGNED TO EXAMINER
Oct 23, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 19, 2024 NWOS
NEW APPLICATION ENTERED
Jun 19, 2024 NWAP